- NeuroQuant®
Lesion Surveillance
Automated quantification, visualization, and longitudinal tracking of brain lesions to support patients undergoing anti-amyloid treatment
NeuroQuant® Lesion Surveillance quantifies brain lesions and their change over time to support radiologists and neurologists in the assessment and longitudinal monitoring of brain changes including those that may occur in Alzheimer’s patients receiving anti-amyloid therapy. By providing consistent, structured lesion quantification across baseline and follow-up MRI exams, NeuroQuant Lesion Surveillance helps clinicians evaluate treatment eligibility and monitor therapy-associated imaging findings over time.
A Complete Solution for Quantitative Lesion Tracking
NeuroQuant® Lesion Surveillance is the first clinically validated solution that identifies and quantifies cerebral microbleeds and superficial siderosis on both T2*GRE and SWI scans. Coupled with FLAIR lesion quantification of cerebral edema, NeuroQuant® Lesion Surveillance offers a complete solution for AI-assisted monitoring of Alzheimer’s Disease patients on anti-amyloid immunotherapies.
*Product features and reports may differ depending on the regulatory clearances in each country.
Benefits
Lesion quantification
Accurate segmentation and longitudinal tracking of FLAIR, T2*GRE, and SWI lesions
Eligibility screening
Objective lesion quantification at baseline, helping clinicians document and contextualize findings
OEM protocol standardization
To ensure reproducible outcomes and accuracy over time
Longitudinal disease tracking
Monitor lesion counts and maximum diameters over time, with comparisons to baseline and prior timepoints
NeuroQuant® Lesion Surveillance reports
Reports that provide quantitative insights to support physicians in tracking FLAIR and T2*GRE/SWI lesions over time compared with a baseline study.
FLAIR Surveillance Report
NeuroQuant Lesion Surveillance FLAIR Report provides analysis and tracking of FLAIR lesions compared with a baseline study, identifying potential sites of involvement, their location and size.
GRE Surveillance Report
NeuroQuant Lesion Surveillance GRE Report provides analysis and tracking of T2*GRE/SWI lesions including microhemorrhage and superficial siderosis counts and locations.
Understanding CPT Codes 0865T & 0866T
As of January 1, 2024, new Category III CPT codes (0865T, 0866T) are active for AI-assisted quantitative brain MRI analysis. These codes apply to a variety of vendor solutions, including Cortechs.ai, and serve as an essential step toward achieving permanent reimbursement.
